National News

50 million doses of Covaxin set to expire in early 2023 due to poor demand

By Odisha News Online Nov 6, 2022 351

HYDERABAD, NOV 6: Nearly 50 million doses of Bharat Biotech’s COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said. Due to lack of product demand, production stoppage of Covaxin- a two dose jab, was initiated by Bharat Biotech […]Continue Reading

National News

DCGI grants EUA to Corbevax for those aged 5-12, Covaxin for 6-12 age group

By Odisha News Online Apr 26, 2022 565

New Delhi, April 26: India’s drug regulator has granted emergency use authorisation for Biological E’s COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech’s Covaxin for children in the age group of six to 12 years, Union Health Minister Mansukh Mandaviya said on Tuesday. The Drugs Controller General of India (DCGI) […]Continue Reading

Odisha News

କୋଭିସିଲ୍ଡ ଓ କୋଭାକ୍ସିନ ବୁଷ୍ଟର ଡୋଜର ମୂଲ୍ୟ ହ୍ରାସ

By Odisha News Online Apr 9, 2022 383

ନୂଆଦିଲ୍ଲୀ, ୯/୪: କେନ୍ଦ୍ର ସ୍ୱାସ୍ଥ୍ୟ ମନ୍ତ୍ରାଳୟ ଘରୋଇ ଟିକାକରଣ କେନ୍ଦ୍ରରେ ୧୮ ବର୍ଷରୁ ଅଧିକ ବର୍ଗଙ୍କ ପାଇଁ କୋଭିଡ-୧୯ ଟିକାର ସତର୍କତାମୂଳକ ତୃତୀୟ ଡୋଜ୍ ବା ବୁଷ୍ଟର ଡୋଜ୍ ରୋଲଆଉଟ୍ ଘୋଷଣା କରିବାର ଗୋଟିଏ ଦିନ ପରେ ଟିକା ମୂଲ୍ୟ ହ୍ରାସ କରିଛନ୍ତି ସେରମ ଇନଷ୍ଟିଚ୍ୟୁଟ୍ ଓ ଭାରତ ବାୟୋଟେକ୍।ଗତକାଲି କୋଭିସିଲ୍ଟ ଟିକା ଟ୍ୟାକ୍ସକୁ ଛାଡ଼ି ୬୦୦ ଟଙ୍କାରେ ଉପଲବ୍ଧ ହେବ ବୋଲି କହିଥିଲେ ସେରମ ଇନଷ୍ଟିଚ୍ୟୁଟର ମୁଖ୍ୟ ଅଦାର ପୁନାୱାଲା।ପରିବର୍ତ୍ତନ ଅଣାଯାଇ Continue Reading

Top Stories

WHO suspends Covaxin supply to UN agencies

By Odisha News Online Apr 3, 2022 425

Hyderabad.April 3 : The World Health Organization (WHO) has confirmed it has suspended the supply of Covaxin, produced by city-based Bharat Biotech, through UN procurement agencies and recommending to countries that received the covid vaccine to take actions as appropriate. A statement issued by WHO on Saturday said the suspension is in response to the […]Continue Reading

National News

AIIMS to begin COVID vaccine human trial from next neek

By Odisha News Online Jul 19, 2020 661

New Delhi, July 19 : In a major development, AIIMS Delhi will begin human trials of India’s first indigenous Covid-19 vaccine, Covaxin, from next week on 100 healthy volunteers aged between 18 and 55. The volunteers will be kept under observation for a period of nearly 150 days. Covaxin is developed by Bharat Biotech in […]Continue Reading